450 nm diode blue laser vaporescetion of the prostate: a report after 100 BPH procedures
10.3969/j.issn.1009-8291.2023.01.006
- VernacularTitle:450 nm蓝激光半导体治疗机汽化切除治疗良性前列腺增生100例报告
- Author:
Zhenwei FAN
1
;
Haifeng CHENG
1
;
Quan DU
1
;
Guoxiong LIU
1
;
Nan LI
1
;
Ximin QIAO
1
;
Xiaofeng XU
1
Author Information
1. Department of Urology, Xianyang Central Hospital, Xianyang 712000, China
- Publication Type:Journal Article
- Keywords:
450 nm blue laser;
prostate vaporescetion;
benign prostatic hyperplasia
- From:
Journal of Modern Urology
2023;28(1):24-28
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the clinical efficacy and safety of transurethral blue laser vaporescetion of the prostate in the treatment of benign prostatic hyperplasia (BPH). 【Methods】 The clinical data of 100 BPH patients undergoing the surgery in our hospital during May and Sep.2022 were retrospectively analyzed. The observations included operation time, bladder irrigation duration, postoperative catheter indwelling time, hospital stay, complications, as well as changes in hemoglobin, International Prostate Symptom Score (IPSS), Quality of Life Scale (QoL) score, maximum urinary flow rate (Qmax), bladder residual urine volume (PVR), and other related indicators before and 3 months after surgery. 【Results】 All 100 procedures were successfully completed without turning to transurethral resection of the prostate and/or open surgery. No blood transfusion was needed. The operation time was (37.8±19.6) min, bladder irrigation time (1.3±0.5) d, catheter indwelling time (12.7±0.4) d, hospital stay (3.4±0.7) d, hemoglobin drop (4.1±7.1) g/L. The postoperative IPSS and QoL score were significantly lower than those before surgery (P<0.05); postoperative Qmax was higher than that before surgery (P<0.05); postoperative PVR was smaller than that before surgery (P<0.05). Urinary retention occurred in 4 cases (4%) after removal of the catheter; carnal hematuria and bladder clot formation occurred in 3 cases (3%); mixed urinary incontinence occurred in 2 cases (2%); stenosis of the external urethra occurred in 2 cases (2%). All complications were cured after symptomatic treatment. There were no serious perioperative complications, no intraoperative complications such as ureteral orifice injury or bladder perforation, and no serious postoperative complications such as transurethral resection syndrome (TURS), permanent urinary incontinence or bladder neck contracture. 【Conclusion】 The blue laser surgical system had satisfactory effects of vaporization and hemostasia. Transurethral blue laser vaporesection of the prostate is safe and effective in the treatment of BPH.
